The treatment of chronic illnesses commonly includes the long-term use of
pharmacotherapy. Although these medications are effective in combating disease, their full …

Despite evidence-based interventions, coronary heart disease (CHD) remains a leading
cause of global mortality. As therapies advance, patient non-adherence to established …

A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal
patient adherence to treatment. However, unsatisfactory rates of adherence to treatment for …

OBJECTIVE: Combination therapy, specifically with aspirin, cholesterol and blood pressure-
lowering drugs, substantially reduces the risk of coronary heart disease, but the full …

Background: For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if β-
blockers are associated with reduced mortality. Objectives: The goal of this study was to …

Background Patients with myocardial infarction (MI) seldom reach recommended targets for
secondary prevention. This study evaluated a smartphone application (“app”) aimed at …

BACKGROUND: Significant disparities exist in cardiovascular outcomes based on
race/ethnicity and gender. Rates of evidence-based medication use and long-term …

Background Nonadherence to chronic disease medications is important. A growing body of
literature suggests that better delivery of established therapies would save more lives than …

Integration of in-person contacts with technology-driven medication adherence reminders,
electronic medication reconciliation, and pharmaceutical databases may improve …

Abstract Background The ISCHEMIA (International Study of Comparative Health
Effectiveness With Medical and Invasive Approaches) trial randomized participants with …